Population pharmacokinetics of cefquinome in pigs

被引:14
作者
Zhao, D. H. [1 ]
Zhang, C. Y. [1 ]
Zhang, Z. [1 ]
Liu, Z. C. [1 ]
Liu, B. T. [1 ]
Yu, J. J. [1 ]
Guo, J. P. [1 ]
Deng, H. [1 ]
Liu, Y. H. [1 ]
机构
[1] South China Agr Univ, Coll Vet Med, Natl Reference Lab Vet Drug Residues SCAU, Guangzhou 510642, Guangdong, Peoples R China
关键词
CRITICALLY-ILL PATIENTS; IN-VITRO ACTIVITY; METABOLITE CIPROFLOXACIN; CONTINUOUS-INFUSION; BIOAVAILABILITY; CEPHALOSPORIN; HEALTHY; COWS; AGE; ENROFLOXACIN;
D O I
10.1111/jvp.12026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was performed in 145 pigs to develop a population pharmacokinetics (PPK) model by i.m. administration of cefquinome (CEQ) at the dose of 2mg/kg in the neck muscle. Serum physiological and biochemical parameters for each pig were determined before administration. After administration, 2-4 samples were collected at random, with the sampling point evenly distributed in the three periods (<1h, 1-4h and >4h). The plasma concentration of CEQ was determined by high performance liquid chromatography with UV detector. The pharmacostatistical analyses of concentration-time data, weight, age, gender, serum physiological and biochemical parameters were performed with nonlinear mixed effect modeling (NONMEM). A one-compartmental model with first-order absorption and elimination adequately described the data from the study group. The optimal random effect model of pharmacokinetics parameters was of log-normal distribution and the residual errors assumed a mixed-type model (proportional and additive) to best explain intra-individual variability. Covariate analysis showed that body weight is positively correlated with apparent volume of distribution (V/F) and body clearance (CL/F). The typical PPK parameters of K-a, CL, and V were 0.564/h, 5.15L/h, and 1.36L, respectively.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 30 条
[1]  
ALBEROLA J, 1993, AM J VET RES, V54, P1112
[2]  
Chen Z., 2009, VET PHARM, V3 ed
[3]   In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum β-lactamase producing strains [J].
Deshpande, L ;
Pfaller, MA ;
Jones, RN .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 15 (04) :271-275
[4]   Population pharmacokinetics of meropenem in burn patients [J].
Doh, Kichan ;
Woo, Heungjeong ;
Hur, Jun ;
Yim, Haejun ;
Kim, Jimyon ;
Chae, Hongseok ;
Han, Seunghoon ;
Yim, Dong-Seok .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) :2428-2435
[5]   THE EFFECT OF AGE ON PHENYLBUTAZONE PHARMACOKINETICS, METABOLISM AND PLASMA-PROTEIN BINDING IN GOATS [J].
ELTOM, SE ;
GUARD, CL ;
SCHWARK, WS .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1993, 16 (02) :141-151
[6]   Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients [J].
Facca, B ;
Frame, B ;
Triesenberg, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1783-1787
[7]   Population pharmacokinetics of continuous infusion ceftazidime [J].
Frame, BC ;
Facca, BF ;
Nicolau, DP ;
Triesenberg, SN .
CLINICAL PHARMACOKINETICS, 1999, 37 (04) :343-350
[8]   Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows [J].
Fu, L. X. ;
Jiang, Z. G. ;
Ding, H. Z. ;
Liu, Y. H. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2008, 31 (03) :240-245
[9]   In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis [J].
Guérin-Faublée, V ;
Carret, G ;
Houffschmitt, P .
VETERINARY RECORD, 2003, 152 (15) :466-471
[10]   Population pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in chicken based on retrospective data, incorporating first-pass metabolism [J].
Guo, Qian-Ji ;
Huang, Ling-Li ;
Fang, Ke ;
Wang, Yu-Lian ;
Chen, Dong-Mei ;
Tao, Yan-Fei ;
Dai, Meng-Hong ;
Liu, Zhen-Li ;
Peng, Peng ;
Yuan, Zong-Hui .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2010, 33 (01) :84-94